MedBen Rx Blog
No Change In Drug Refill Policy Recommended
With the novel coronavirus COVID-19 a constant topic in the news nowadays, many consumers are stocking up on various drugs. MedBen is recommending no change to the current prescription drug refill guidelines for our clients and here’s why: Most wholesalers have a good...
Research Suggests Statins Linked to Anti-Cancer Benefits
According to American Heart Association, about 40 million adults in the U.S. take a statin to lower their cholesterol and reduce the risk for heart disease – and new research suggests that they might also be getting an added anti-cancer benefit. The study found that...
Heart Medication Therapy Can Be Just as Effective as Surgery
At the annual meeting of the American Heart Association, researchers reported that patients who received drug therapy alone did not experience more heart attacks or die more often than those who also received bypass surgery or stents – further evidence that a...
With MedBen Rx, Employers Pay Only What’s Necessary
The MedBen Rx approach to drug pricing is straightforward. We keep client costs low by reimbursing pharmacies what they pay for prescription drugs, plus a reasonable dispensing fee. By doing so, we ensure that self-funded employers get the maximum value from their...
Price Disclosure in Rx Ads Doesn’t Tell Full Story
The Trump administration recently announced that drug makers will now have to include prices in their TV advertising beginning this summer. Prescription drug cost transparency is a good thing… and MedBen makes transparency a keystone of its pharmacy plans, so clients...
MedBen Introduces Enhanced Reporting Platform
To give employers the most accurate and up-to-date information possible, MedBen has partnered with Deerwalk, Inc. to provide an upgraded data analytics and reporting platform. The strong reporting that MedBen clients come to expect is now even stronger. With our...
Overprescribing Drugs Raises Costs, Health Risks
The ongoing movement to reduce prescription drug spending focuses primarily on the cost factor. But as Shannon Brownlee and Judith Garber contend in a Stat opinion piece, overprescribing of drugs also carries financial and health risks. "Between 2000 and 2012, the...
Rx Spending Hikes Call for Smart Solutions
In just four years, U.S. retail prescription drug spending grew nearly 27%... a substantial increase that illustrates the need for pharmacy solutions like those available through MedBen Rx. A new report from the Pew Charitable Trusts found that annual spending on...
Government Fixes to Rx Prices a Slippery Slope
A recent Wall Street Journal editorial warns that government efforts to address prescription drug prices could produce undesirable consequences… and it's why MedBen Rx believes that market-driven solutions are the preferable method to reducing consumer costs. As the...
Biggest? Nope. Best? That’s the Goal.
High-profile health care companies continue to buy each other in an effort to be “biggest and best.” Meanwhile, MedBen continues to grow as it has for over 80 years... by providing clients with superior benefits management services. A quick recap: Anthem Health will...
While Titans Battle Over Drug Costs, MedBen Rx Offers Solutions
A recent high-profile disagreement between Walmart and pharmacy benefits manager (PBM) CVS Caremark exemplifies the friction between pharmacies and PBMs about prescription pricing... and the power that PBMs possess to influence drug costs. MedBen Rx was designed to...
Fight Back Against New Year’s Drug Price Increases
New year, higher drug prices. According to The Wall Street Journal, a representative analysis of major pharmaceutical companies found that the prices of their brand name and generic drugs have risen by an average of 6.3% in 2019 – modest compared to previous years,...